NEW YORK – As new variants of SARS-CoV-2 continue to emerge, clinical labs are having to develop new and evolve existing approaches to test for the virus.
While existing molecular tests appear to be capable of detecting the new UK and South Africa SARS-Cov-2 strains that have been the focus of much recent attention and concern, the appearance of these and other variants could require changes in labs' testing processes and the development of better tools for monitoring the presence of relevant variants in the patients they serve.